Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Nov 6, 2026, 4:00 PM EST
1.320
+0.040 (3.13%)
After-hours: Nov 6, 2026, 7:35 PM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $340.69 million as of November 6, 2026. It is the 16,959th most valuable company in the world and the 3,035th biggest in the United States. Its market cap has decreased by 7.57% in one year.
Market Cap
340.69M
Enterprise Value
506.87M
1-Year Change
-7.57%
Global Rank
Country Rank
#3,035 United States
Category
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $340.69M, a decrease of -63.93%. That is a compound annual growth rate of -11.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 340.70M | -35.67% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 359.31M |
| TRex Bio | 356.99M |
| Opus Genetics | 347.76M |
| Atea Pharmaceuticals | 345.68M |
| ProKidney | 344.65M |
| Fennec Pharmaceuticals | 344.01M |
| Orchestra BioMed Holdings | 341.40M |
| Alector | 339.51M |